Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

293031323334353637

Astra's CinCor buy to help ease possible farxiga generic drug pressure

9th Jan 2023 10:19

(Alliance News) - AstraZeneca PLC unveiled its first acquisition of the year on Monday, forking out just shy of USD2 billion for a buy which could ease pressure on its cardiorenal arm amid an upcoming loss of exclusivity. Read More

TOP NEWS: AstraZeneca buys biotech CinCor for up to USD1.8 billion

9th Jan 2023 09:11

(Alliance News) - AstraZeneca PLC on Monday said it has acquired CinCor Pharma Inc for an upfront cash consideration of around USD1.3 billion, though the fee could rise to USD1.8 billion. Read More

LONDON BRIEFING: Astra makes USD1.8 billion buy; Keller hit by fraud

9th Jan 2023 07:49

(Alliance News) - London's FTSE 100 was called to start the new week higher, after a strong handover from Asia on Monday and a bullish end to the first week of the year in New York. Read More

LONDON BROKER RATINGS: Credit Suisse cuts Next to 'underperform'

6th Jan 2023 09:22

(Alliance News) - The following London-listed shares received analyst recommendations late Thursday and Friday morning: Read More

LONDON BROKER RATINGS: Bank of America cuts Pearson to 'underperform'

5th Jan 2023 09:20

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon: Read More

TOP NEWS: AstraZeneca's and Sanofi's nirsevimab approved for US review

5th Jan 2023 07:47

(Alliance News) - AstraZeneca PLC and its partner Sanofi SA on Thursday said nirsevimab, their antibody against respiratory syncytial virus, has been approved for review by the US Food & Drug Administration for preventing RSV lower respiratory tract disease in newborns and infants up to 24 months of age. Read More

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

3rd Jan 2023 09:24

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday: Read More

LONDON MARKET MIDDAY: FTSE 100 rises with positive 2022 in sight

28th Dec 2022 12:15

(Alliance News) - Stock prices in London were higher at midday on Wednesday, with sentiment remaining upbeat as investors looked to the year-end after the Christmas break. Read More

TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan

28th Dec 2022 07:51

(Alliance News) - AstraZeneca PLC on Wednesday said it won approvals for cancer treatment for adults in Japan. Read More

LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals

28th Dec 2022 07:40

(Alliance News) - Stocks in London are set to open higher on Wednesday as UK markets returned to business following the Christmas break. Read More

AstraZeneca wins two new approvals in EU for cancer drugs

21st Dec 2022 09:16

(Alliance News) - AstraZeneca PLC on Wednesday said it won two new drug approvals in the European Union for Imfinzi and Lynparza to treat cancer. Read More

LONDON MARKET OPEN: European markets make gains in early trade

21st Dec 2022 09:00

(Alliance News) - Stock prices in London opened higher on Wednesday, while official statistics showed a surge in UK government borrowing, as Westminster forks out billions for its energy support scheme. Read More

LONDON BRIEFING: UK public sector borrowing shoots up in November

21st Dec 2022 07:55

(Alliance News) - Stock prices in London were called to open higher on Wednesday, after a positive finish on Wall Street. Read More

TOP NEWS: AstraZeneca receives host of EU approvals or recommendations

19th Dec 2022 09:46

(Alliance News) - AstraZeneca PLC on Monday said it received a host of approvals or recommendations for approval for a handful of prospective treatments in the EU, but noted disappointing phase 3 trial results for Imfinzi. Read More

LONDON MARKET OPEN: Stocks higher as China begins shaky reopening

19th Dec 2022 08:55

(Alliance News) - Stock prices in London opened higher on Monday, but the FTSE 100 was lagging behind European counterparts, despite gains for oil and mining stocks. Read More

LONDON BRIEFING: Stocks called up, but prospect of Santa rally fades

19th Dec 2022 07:52

(Alliance News) - The FTSE 100 index looked set to regain some lost ground early on Monday, having fallen to a four-week low last week. Read More

HealthBeacon appoints new interim CFO, permanent CFO process ongoing

16th Dec 2022 10:27

(Alliance News) - HealthBeacon PLC on Friday said it appointed a new interim chief financial officer, while the process to appoint a CFO on a permanent basis is ongoing. Read More

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership

15th Dec 2022 12:13

(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner programme with AstraZeneca PLC. Read More

LONDON BROKER RATINGS: Goldman Sachs likes Big Yellow, Great Portland

15th Dec 2022 09:25

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

AstraZeneca and Merck receive US FDA extension for Lynparza review

15th Dec 2022 08:37

(Alliance News) - AstraZeneca PLC on Thursday alongside US peer Merck & Co, announced that the US Food & Drug Administration will extend the Prescription Drug User Fee Act date by three months to allow further time for a full review of the supplementary new drug application of Lynparza in combination with abiraterone and prednisone or prednisolone. Read More

293031323334353637
FTSE 100 Latest
Value9,491.25
Change63.52